Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

NCT00541476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 746

Last updated 2021-01-22

No results posted yet for this study

Summary

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.

Conditions

  • Neuralgia

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-12-31
Completion
2007-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541476 on ClinicalTrials.gov